MAPT and Alzheimer disease: Recent studies have shown the possibility of different treatment approaches based on the pathogenesis of AD not only using combination therapies including Aβ and tau but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, and epigenetics [94–98].